DAWEX
22.4.2024 08:31:26 CEST | Business Wire | Press release
Data4Industry-X, the trusted data exchange solution for Industry, carries on its dynamics to bring the most comprehensive and flexible solution on the market for industrial organizations aiming at boosting competitiveness and minimizing carbon footprint. Recognized as a Gaia-X Lighthouse project and contributing to the Manufacturing-X initiative, the Data4Industry-X solution is designed to accelerate data & information exchange between global organizations, subsidiaries and suppliers by leveraging the most advanced, secure and compliant data exchange technology on the market.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240421440918/en/
Supported by the AIF (Alliance pour l’industrie du futur), and initially responding to the power generation and automotive markets, Data4Industry-X gathers technological & industrial expertise from Dawex, Schneider Electric, Valeo, CEA, and Prosyst, in order to deliver broad cross-border, cross-company, cross-factory industrial data exchanges.
Industrial organizations with plants, shop floors and suppliers, spread across the globe with decentralized manufacturing, are concerned by their ability to bring innovations and operational efficiencies to increase competitiveness, while reducing CO2 emissions to meet and report on their sustainability obligations.
With the objective to support the digital transformation of all industry stakeholders and create a compelling industry data ecosystem encompassing all sizes of organizations, Data4Industry-X solution relies on Dawex Data Exchange technology. The solution is based on open and cloud-agnostic architecture, to deliver a trusted, secure, sovereign and compliant data exchange environment that implements the Gaia-X de facto standards. Powered by this technology, the Data4Industry-X solution will use the Eclipse Dataspace Component framework to facilitate interoperability between data spaces. Additionally, thanks to the UDC (Unified Data Collector) Prosyst solution, Data4Industry-X interfaces with OPC UA protocol to retrieve industrial data and exchange them at scale with the broad ecosystem.
By relying on technological and industrial expertise, Data4Industry-X becomes the most agnostic, flexible and advanced data exchange solution for Industry, designed in compliance with the new European data regulations, such as the Data Act and the Data Governance Act, capable of operating in any industrial situation, with all types of companies.
The Data4Industry-X solution will bridge the entire industry data ecosystem by enabling large and small organizations in all sectors to exchange, distribute and valorize industrial data, securely, to ultimately improve operational efficiency and meet decarbonation objectives.
“Data4Industry-X pursues its dynamics to deploy the most advanced data exchange solution for the industry to accelerate innovation, better control carbon footprint, and gain competitive advantage thanks to data circulation.” said Laurent Lafaye, co-CEO at Dawex. “Data4Industry-X will ultimately empower all industry stakeholders, of all sizes, to engage into data exchange and contribute to fostering a resilient and sustainable industry ecosystem by benefiting from the full potential of data”.
Data4Industry-X is supported by the French government’s France 2030 initiative and the European program Next Generation.
About Dawex
About Schneider Electric
About Valeo
About CEA-List
About Prosyst
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240421440918/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Incyte Announces Positive CHMP Opinion for Zynyz® (retifanlimab) for First-Line Treatment of Advanced Squamous Cell Carcinoma of the Anal Canal (SCAC)30.1.2026 15:29:00 CET | Press release
Pending the European Commission decision, Zynyz® (retifanlimab) in combination with carboplatin and paclitaxel (platinum-based chemotherapy) will be the first PD-1 immunotherapy treatment for patients with advanced squamous cell carcinoma of the anal canal (SCAC) in EuropeGlobally, the prevalence of SCAC is estimated at around 1 or 2 cases per 100,000 people, with a higher incidence in women than in men1,2,3The Committee for Medicinal Products for Human Use (CHMP) positive opinion is based on data from the Phase 3 POD1UM-303/InterAACT2 trial which showed patients with advanced SCAC achieved significantly improved progression-free survival with Zynyz in combination with carboplatin and paclitaxel as a first-line treatment4 Incyte (Nasdaq:INCY) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has issued a positive opinion recommending the approval of Zynyz® (retifanlimab) in combination with carboplatin and paclitaxel (
Mediawan to Acquire The North Road Company, Creating a New Global Independent Content Platform30.1.2026 13:32:00 CET | Press release
Mediawan, the leading independent European studio led by Pierre-Antoine Capton, co-founded by Capton, Xavier Niel and Matthieu Pigasse, today announced the signing of an agreement to acquire The North Road Company (“North Road”), the preeminent independent U.S.-based studio founded by Peter Chernin. The combination creates one of the world’s largest independent studios with major creative hubs in the five continents and capabilities spanning all genres, formats and audiences. Together, Mediawan and North Road will have a stronger ability to accelerate the development of powerful IP, foster fresh creative synergies through format adaptations and co-production opportunities, and deliver ever greater value to viewers, talent and partners worldwide. The acquisition brings together two of the most dynamic independent studios in the sector with world-class creative talent, premium IP, and the scale to deliver content at the highest level. In an industry undergoing significant consolidation,
BrightSign Powers Intelligent Signage Experiences at ISE 202630.1.2026 09:00:00 CET | Press release
The Latest Players and AI Capabilities Drive Captivating, Personalized, and Interactive Signage With more industries embracing the power of visual storytelling, BrightSign, the provider of the most advanced, capable, and trusted digital media players and operating system, will showcase the latest developments in digital signage technology at ISE 2026 in Barcelona, Spain from February 3-6, 2026. BrightSign’s latest innovations come to life at booth #4S-150 through interactive real-world demos featuring retail, QSR, transportation, and corporate use cases. Visitors can test new AI-powered object detection capabilities of BrightSign players, allowing them to pick up an object and see the content on the screen respond immediately. Booth activations will be powered by BrightSign’s reliable platform including bsn.Control, BrightSignOS™, brightAuthor connected, and its global partner ecosystem. “In today’s immersive, personalized and visual world, the stakes have never been higher for powerfu
Candela Ushers in a New Era of Aesthetic Innovation at IMCAS Paris With the Launch of the Glacē™ System30.1.2026 08:30:00 CET | Press release
Iconic Vbeam® Pro and Matrix™ Systems showcased ahead of broader commercial availability Candela, a global leader in energy-based aesthetic technologies, today announced the European launch of the Glacē™ System, a facial treatment platform that signals a bold new chapter for the company and the future of aesthetic medicine. In addition to the launch of the Glacē System, Candela will also showcase its Matrix system for radiofrequency-based skin renewal and its iconic Vbeam® Pro vascular treatment platform at IMCAS 2026. Both Matrix and VBeam Pro platforms are currently available in select EMEA markets and are expected to be comprehensively launched shortly, further strengthening Candela’s leadership in the energy-based device market. Unveiled at the IMCAS World Congress 2026, these launches underscore Candela’s continued commitment to delivering innovative, science-backed treatment solutions for high-demand patient needs. Candela leads the industry in clinical efficacy and safety, suppo
Merz Therapeutics Appoints Dan Staner as President, Region Europe30.1.2026 08:00:00 CET | Press release
Merz Therapeutics today announced the appointment of Dan Staner as President, Region Europe, effective February 1, 2026. In this role, Dan will oversee the company’s European business and drive regional growth. Dan will report directly to Merz Therapeutics Chief Executive Officer, Stefan König, and will join the Therapeutics Executive Team. His appointment reflects the company’s continued commitment to strengthening its leadership capabilities and accelerating its growth strategy across key European markets. “Dan brings a strong track record of building and scaling biopharmaceutical businesses across Europe,” said Stefan König, CEO of Merz Therapeutics. “His deep commercial, strategic, and regional leadership experience will be instrumental in advancing our growth ambitions, expanding patient access to our therapies, and further strengthening our presence in Europe. We are very pleased to welcome Dan to Merz Therapeutics.” Throughout his career, Dan has held senior leadership roles i
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom